Hedge Fund - Portolan Capital Management
Abiomed Inc (NASD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $ |
| 2 | 2022 - Q3 (2022-09-30) | $1,754,000 | 0.18% | 7,139 | $ |
| 3 | 2022 - Q2 (2022-06-30) | $1,771,000 | 0.17% | 7,154 | $338.64 |
| 4 | 2022 - Q1 (2022-03-31) | $2,370,000 | 0.18% | 7,154 | $307.83 |
| 5 | 2021 - Q4 (2021-12-31) | $2,545,000 | 0.17% | 7,085 | $337.86 |
| 6 | 2021 - Q3 (2021-09-30) | $2,301,000 | 0.16% | 7,070 | $338.77 |
| 7 | 2021 - Q2 (2021-06-30) | $2,226,000 | 0.16% | 7,133 | $306.77 |
| 8 | 2021 - Q1 (2021-03-31) | $2,300,000 | 0.18% | 7,215 | $320.02 |
| 9 | 2020 - Q4 (2020-12-31) | $2,346,000 | 0.21% | 7,237 | $276.60 |
| 10 | 2020 - Q3 (2020-09-30) | $2,127,000 | 0.24% | 7,677 | $288.09 |
| 11 | 2020 - Q2 (2020-06-30) | $2,025,000 | 0.23% | 8,385 | $200.79 |
| 12 | 2020 - Q1 (2020-03-31) | $1,764,000 | 0.26% | 12,155 | $166.01 |
| 13 | 2019 - Q4 (2019-12-31) | $4,309,000 | 0.43% | 25,260 | $185.40 |
| 14 | 2019 - Q3 (2019-09-30) | $645,000 | 0.07% | 3,628 | $216.16 |
| 15 | 2019 - Q2 (2019-06-30) | $934,000 | 0.1% | 3,584 | $265.32 |
| 16 | 2019 - Q1 (2019-03-31) | $994,000 | 0.1% | 3,481 | $332.35 |
| 17 | 2018 - Q4 (2018-12-31) | $1,131,000 | 0.14% | 3,481 | $347.37 |
| 18 | 2018 - Q3 (2018-09-30) | $1,655,000 | 0.16% | 3,680 | $394.20 |
| 19 | 2018 - Q2 (2018-06-30) | $1,923,000 | 0.19% | 4,700 | $362.28 |
| 20 | 2018 - Q1 (2018-03-31) | $2,095,000 | 0.22% | 7,199 | $253.43 |
| 21 | 2017 - Q4 (2017-12-31) | $4,205,000 | 0.46% | 22,440 | $186.71 |
| 22 | 2017 - Q3 (2017-09-30) | $7,798,000 | 0.92% | 46,254 | $151.21 |
| 23 | 2017 - Q2 (2017-06-30) | $8,695,000 | 1.11% | 60,676 | $134.39 |
| 24 | 2017 - Q1 (2017-03-31) | $10,304,000 | 1.33% | 82,298 | $115.92 |
| 25 | 2016 - Q4 (2016-12-31) | $5,798,000 | 0.78% | 51,456 | $115.85 |
| 26 | 2016 - Q3 (2016-09-30) | $3,972,000 | 0.54% | 30,888 | $119.78 |
| 27 | 2016 - Q2 (2016-06-30) | $5,215,000 | 0.75% | 47,720 | $99.49 |
| 28 | 2016 - Q1 (2016-03-31) | $7,258,000 | 0.97% | 76,550 | $84.41 |
| 29 | 2015 - Q4 (2015-12-31) | $7,142,000 | 0.9% | 79,110 | $84.86 |
| 30 | 2015 - Q3 (2015-09-30) | $9,567,000 | 1.26% | 103,138 | $88.11 |
| 31 | 2015 - Q2 (2015-06-30) | $17,612,000 | 2.46% | 267,940 | $66.44 |
| 32 | 2015 - Q1 (2015-03-31) | $15,651,000 | 2.87% | 218,648 | $54.28 |
| 33 | 2014 - Q4 (2014-12-31) | $10,790,000 | 2.16% | 283,507 | $31.54 |
| 34 | 2014 - Q3 (2014-09-30) | $10,161,000 | 2.3% | 409,211 | $25.33 |
| 35 | 2014 - Q2 (2014-06-30) | $8,467,000 | 1.84% | 336,777 | $23.27 |
The displayed share prices are average quarterly stock market prices.